Roche said it would increase its dividend after its hemophilia injection Hemlibra and multiple sclerosis treatment Ocrevus lifted sales in the first nine months of the year.
Related Posts
Health Care Roundup: Market Talk
Find insight on Pfizer, Riverstone, Top Glove Corp. and more in the latest Market Talks covering the Health Care sector.
Denmark to Pay $4.5 Billion for Majority Stake in Copenhagen Airports
The deal would increase the Danish government’s stake in the airport operator to 98.6% and ensure the hub continues to contribute positively to the economy, […]
Evolution Mining Founder Isn’t Finished Yet
With tailwinds from a record-high gold price, Evolution is racing to pay down debt accumulated from acquisitions and to show investors that a difficult Canadian […]